Structuring, industrial sale and post-merger integration
A company active in the development and production of innovative healthcare technologies, from clinical research to patient-facing solutions. A full sale of shares with a plan for subsequent growth in scale.
Thera Capital's initial role
Sell-side advisor for a company operating in medical technology, with EBITDA of around 50%.
Work carried out
Advisor across the entire span of the project. First, structuring the company, with planning, management control, monitoring of the commercial area and the addition of new organizational roles. Then the search for a buyer and the sale to a foreign industrial group, leading every phase of the deal through to closing.
Thera Capital's subsequent role
Italian financial and tax advisor to the foreign group for post-acquisition support, acting as temporary CFO, reporting to the parent company and preparing the development plan for external lines of growth.
KPIs achieved
Preparation of the company for the capital markets: 18 months
Duration of the sell-side transaction, from first contact to closing: 7 months